bropair spiromax
teva b.v. - salmeterol xinafoate, flútikasón nef - astma - lyf til veikindi öndunarvegi sjúkdómum, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
seffalair spiromax
teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.
flutiform (affilia) innúðalyf, dreifa 125 míkróg/5 míkróg
mundipharma a/s - fluticasonum própíónat; formoterolum fúmarat - innúðalyf, dreifa - 125 míkróg/5 míkróg
flutiform (affilia) innúðalyf, dreifa 250 míkróg/10 míkróg
mundipharma a/s - fluticasonum própíónat; formoterolum fúmarat - innúðalyf, dreifa - 250 míkróg/10 míkróg
flutiform (affilia) innúðalyf, dreifa 50 míkróg/5 míkróg
mundipharma a/s - fluticasonum própíónat; formoterolum fúmarat - innúðalyf, dreifa - 50 míkróg/5 míkróg
bufomix easyhaler innöndunarduft 160 míkróg/4,5 míkróg/skammt
orion corporation - budesonidum inn; formoterolum fúmarat - innöndunarduft - 160 míkróg/4,5 míkróg/skammt
bufomix easyhaler innöndunarduft 320 míkróg/9 míkróg/skammt
orion corporation - budesonidum inn; formoterolum fúmarat - innöndunarduft - 320 míkróg/9 míkróg/skammt
symbicort forte turbuhaler innöndunarduft 320/9 míkróg/skammt
astrazeneca a/s - budesonidum inn; formoterolum fúmarat - innöndunarduft - 320/9 míkróg/skammt
symbicort mite turbuhaler innöndunarduft 80/4,5 míkróg/skammt
astrazeneca a/s - budesonidum inn; formoterolum fúmarat - innöndunarduft - 80/4,5 míkróg/skammt
symbicort turbuhaler innöndunarduft 160/4,5 míkróg/skammt
astrazeneca a/s - budesonidum inn; formoterolum fúmarat - innöndunarduft - 160/4,5 míkróg/skammt